Literature DB >> 17664425

Existence of transient functional double-stranded DNA intermediates during recombinant AAV transduction.

Jinhui Wang1, Jing Xie, Hui Lu, Lingxia Chen, Bernd Hauck, Richard Jude Samulski, Weidong Xiao.   

Abstract

Previous studies have documented that 0.1 approximately 1% of input recombinant adeno-associated virus (rAAV) vectors could be stabilized and lead to transgene expression. To characterize the steps involving massive AAV DNA loss, we designed an"AAV footprinting" strategy that can track newly formed AAV dsDNA genomes. This strategy is based on an ROSA26R mouse model or cell line that carries a lacZ gene flanked by two loxP sites. When it is transduced by a rAAV vector carrying the Cre recombinase, the lacZ gene can be activated and remain active even when rAAV genomes are later lost. By using this sensitive AAV footprinting technique, we confirmed the existence of transient AAV dsDNA that went undetected by conventional DNA methods. Although these dsDNA intermediates could be efficiently formed in almost every cell and were competent for mRNA transcription and protein synthesis in vivo, they got lost continuously. Only a small fraction was eventually stabilized for sustained gene expression. Although both rAAV2 and rAAV8 can potentially have similar levels of dsDNA formation, AAV8 dsDNA was formed much faster than that of AAV2, which explains why rAAV8 is more efficient than rAAV2 in transducing the liver. Collectively, our studies suggested that rather than receptor binding, viral entry, and ssDNA to dsDNA conversion, the instability of newly formed AAV dsDNA was the primary contributing factor for the low rAAV transduction efficacy. The uncoating step significantly influenced the stability of AAV transient dsDNA. The identification of transient AAV dsDNA provided a new pathway for improving rAAV transduction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664425      PMCID: PMC1941794          DOI: 10.1073/pnas.0702778104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts.

Authors:  J Hansen; K Qing; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Real-time single-molecule imaging of the infection pathway of an adeno-associated virus.

Authors:  G Seisenberger; M U Ried; T Endress; H Büning; M Hallek; C Bräuchle
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

3.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Looking into the safety of AAV vectors.

Authors:  Mark A Kay; Hiroyuki Nakai
Journal:  Nature       Date:  2003-07-17       Impact factor: 49.962

5.  Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.

Authors:  H Nakai; S R Yant; T A Storm; S Fuess; L Meuse; M A Kay
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

6.  Subthalamic GAD gene therapy in a Parkinson's disease rat model.

Authors:  Jia Luo; Michael G Kaplitt; Helen L Fitzsimons; David S Zuzga; Yuhong Liu; Michael L Oshinsky; Matthew J During
Journal:  Science       Date:  2002-10-11       Impact factor: 47.728

7.  Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus.

Authors:  D Duan; Y Yue; Z Yan; J Yang; J F Engelhardt
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction.

Authors:  C H Miao; H Nakai; A R Thompson; T A Storm; W Chiu; R O Snyder; M A Kay
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation.

Authors:  A M Douar; K Poulard; D Stockholm; O Danos
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

View more
  35 in total

1.  Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cells.

Authors:  Jeffrey M Zirger; Mariana Puntel; Josee Bergeron; Mia Wibowo; Rameen Moridzadeh; Niyati Bondale; Carlos Barcia; Kurt M Kroeger; Chunyan Liu; Maria G Castro; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

Review 2.  Recombinant adeno-associated virus transduction and integration.

Authors:  Brian R Schultz; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-05-20       Impact factor: 11.454

3.  Proteasome inhibitors decrease AAV2 capsid derived peptide epitope presentation on MHC class I following transduction.

Authors:  Jonathan D Finn; Daniel Hui; Harre D Downey; Danielle Dunn; Gary C Pien; Federico Mingozzi; Shangzhen Zhou; Katherine A High
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

4.  Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing.

Authors:  Philipp Kapranov; Lingxia Chen; Debra Dederich; Biao Dong; Jie He; Kathleen E Steinmann; Andrea R Moore; John F Thompson; Patrice M Milos; Weidong Xiao
Journal:  Hum Gene Ther       Date:  2011-10-04       Impact factor: 5.695

5.  Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype.

Authors:  Nalinda B Wasala; Yi Lai; Jin-Hong Shin; Junling Zhao; Yongping Yue; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2016-04-22       Impact factor: 6.150

6.  Functional analysis of the putative integrin recognition motif on adeno-associated virus 9.

Authors:  Shen Shen; Garrett E Berry; Ruth M Castellanos Rivera; Roland Y Cheung; Andrew N Troupes; Sarah M Brown; Tal Kafri; Aravind Asokan
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

7.  Recombinant AAV2-mediated β-globin expression in human fetal hematopoietic cells from the aborted fetuses with β-thalassemia major.

Authors:  Jing Tian; Feng Wang; Jin-Feng Xue; Fei Zhao; Liu-Jiang Song; Meng-Qun Tan
Journal:  Int J Hematol       Date:  2011-05-27       Impact factor: 2.490

8.  Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.

Authors:  Jarrod S Johnson; Chengwen Li; Nina DiPrimio; Marc S Weinberg; Thomas J McCown; R Jude Samulski
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

9.  Effect of elongation factor 1alpha promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase.

Authors:  Carlos J Alméciga-Díaz; Maria A Rueda-Paramo; Angela J Espejo; Olga Y Echeverri; Adriana Montaño; Shunji Tomatsu; Luis A Barrera
Journal:  Mol Biol Rep       Date:  2008-11-07       Impact factor: 2.316

10.  Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints.

Authors:  L H Vandenberghe; E Breous; H-J Nam; G Gao; R Xiao; A Sandhu; J Johnston; Z Debyser; M Agbandje-McKenna; J M Wilson
Journal:  Gene Ther       Date:  2009-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.